COPD: Providing the right treatment for the right patient at the right time
![](https://catedrasaludrespiratoria.com/wp-content/uploads/2023/01/COPD-Providing-the-right-treatment-for-the-right-patient-at-the-right-time.jpg)
Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with significant morbidity and mortality that is both preventable and treatable.
However, a major challenge in recognizing, preventing, and treating COPD is understanding its complexity. While COPD has historically been characterized as a disease defined by airflow limitation, we now understand it as a multi-component disease with many clinical phenotypes, systemic manifestations, and associated co-morbidities.
Puedes leer el artículo completo en el siguiente enlace: https://www.resmedjournal.com/article/S0954-6111(22)00306-7/fulltext#secsectitle0010
Autores:
Alvar Agusti, Nicolino Ambrosino, Felicity Blackstock, Jean Bourbeau, Richard Casaburi, Bartolome Celli, Rebecca Crouch,Roberto Dal Negro,, Michael Dreher, Christine Garvey, Daniel Gerardi, Roger Goldstein, Nicola Hanania, Anne E. Holland, Antarpreet Kaur, Suzanne Lareau, Peter K., Lindenauer, David Mannino, Barry Make, François Maltais, Jeffrey D. Marciniuk, Paula Meek, Mike Morgan, Jean-Louis, Pepin, Jane Z. Reardon, Carolyn, Rochester, Sally Singh, Martijn, A. Spruit, Michael C. Steiner, Thierry Troosters, Michele, Vitacca, Enico Clini, Jose Jardim, Linda Nici, Jonathan Raskin, Richard ZuWallack.
Noticias relacionadas
![Polygenic Risk Score for COPD](https://catedrasaludrespiratoria.com/wp-content/uploads/2024/07/Polygenic-Risk-Score-for-COPD-opt-300x225.webp)
Association of a polygenic risk score for chronic obstructive pulmonary disease with lung function across the lifespan
Discover the strong associations between a polygenic risk score for COPD and lung function from childhood to elderly. Study includes individuals aged 4-84 years, revealing significant links from school age to elderly.
![Bayesian modelling of FEV1 and FVC trajectories](https://catedrasaludrespiratoria.com/wp-content/uploads/2024/07/Bayesian-modelling-of-FEV1-and-FVC-trajectories-300x225.webp)
Bayesian modelling of combined FEV1 and FVC vital lung function trajectories: relationship with airflow obstruction and PRISm
Discover how Bayesian non-parametric trajectory modeling identified seven combined FEV1 and FVC life-course trajectories and their association with airflow obstruction (AO) and PRISm. Learn about the prevalence and onset age across trajectories based on the Framingham Offspring Cohort study.
Más artículos
EPOC
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768778·Alvar Agusti, Claus F. Vogelmeier – GOLD 2024: a brief overview of key changes
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
- 769092·Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
COPD
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
Recuerda que puedes acceder a varios enlaces a artículos en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imágenes obtenidas el 19/01/2023 en Canva Pro.